Davis's Drug Guide
fentaNYL (transdermal)
General
High Alert Medication: This medication bears a heightened risk of causing significant patient harm when it is used in error.
**REMS Drug**
Pronunciation:
fen-ta-nil
To hear audio pronunciation of this topic, purchase a subscription or log in.Trade Name(s)
- Duragesic
Ther. Class.
Pharm. Class.
opioid agonists
Controlled Substance Schedule: II
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "FentaNYL (transdermal)." Davis's Drug Guide, 19th ed., F.A. Davis Company, 2026. The Washington Manual, www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/51303/all/fentaNYL__transdermal_.
Vallerand AHA, Sanoski CAC, . FentaNYL (transdermal). Davis's Drug Guide. F.A. Davis Company; 2026. https://www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/51303/all/fentaNYL__transdermal_. Accessed May 30, 2026.
Vallerand, A. H., Sanoski, C. A., & , (2026). FentaNYL (transdermal). In Davis's Drug Guide (19th ed.). F.A. Davis Company. https://www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/51303/all/fentaNYL__transdermal_
Vallerand AHA, Sanoski CAC, . FentaNYL (transdermal) [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2026. [cited 2026 May 30]. Available from: https://www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/51303/all/fentaNYL__transdermal_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - fentaNYL (transdermal)
ID - 51303
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - ,,
BT - Davis's Drug Guide
UR - https://www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/51303/all/fentaNYL__transdermal_
PB - F.A. Davis Company
ET - 19
DB - The Washington Manual
DP - Unbound Medicine
ER -
